References
- Ahmed S, Ihara K, Kanemitsu S, Nakashima H, Otsuka T, Tsuzaka K, Takeuchi T, Hara T. 2001. Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in Japanese population. Rheumatology 40:662–667.
- Chew CH, Chua KH, Lian LH, Puah SM, Tan SY. 2008. PCR-RFLP genotyping of C1q mutations and single nucleotide polymorphisms in Malaysian patients with systemic lupus erythematosus. Hum Biol 80:83–93.
- Deichmann K., Heinzmann A, Bruggenolte E, Forster J, Kuehr J. 1996. An MseI. RFLP in the human CTLA-4 promotor. Biochem Biophys Res Commun 225:817–818.
- Fernandez-Blanco L, Perez-Pampin E, Gomez-Reino JJ, Gonzalez A. 2004. A CTLA-4 polymorphism associated with susceptibility to systemic lupus erythematosus. Arthritis Rheum 50:328–329.
- Harper K, Balzano C, Rouvier E, Mattei MG, Luciani MF, Golstein P. 1991. CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J Immunol 147:1037–1044.
- Hudson LL, Rocca K, Song YW, Pandey JP. 2002. CTLA-4 gene polymorphisms in systemic lupus erythematosus: A highly significant association with a determinant in the promoter region. Hum Genet 111:452–455.
- Liu MF, Wang CR, Lin LC, Wu CR. 2001. CTLA-4 gene polymorphism in promoter and exon-1 regions in Chinese patients with systemic lupus erythematosus. Lupus 10:647–649.
- Kristiansen OP, Larsen ZM, Pociot F. 2000. CTLA-4 in autoimmune disease – a general susceptibility gene to autoimmunity? Genes Immun 1:170–184.
- Matsushita M, Tsuchiya N, Shiota M, Komata T, Matsuta K, Zama K, Oka T, Juji T, Yamane A, Tokunaga K. 1999. Lack of a strong association of CTLA-4 exon 1 polymorphism with the susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese: An association study using a novel variation screening method. Tissue Antigens 54:578–584.
- Nistico L, Buzzetti R, Pritchard LE, Van der Auwera B, Giovannini C, Bosi E, Larrad MT, Rios MS, Chow CC, Cockram CS 1996. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum Mol Genet 5:1075–1080.
- Pullmann R Jr, Lukac J, Skerenova M, Rovensky J, Hybenova J, Melus V, Celec S, Pullmann R, Hyrdel R. 1999. Cytotoxic T lymphocyte antigen 4 (CTLA-4) dimorphism in patients with systemic lupus erythematosus. Clin Exp Rheumatol 17:725–729.
- Purohit S, Podolsky R, Collins C, Zheng W, Schatz D, Muir A, Hopkins D, Huang YH, She JX. 2005. Lack of correlation between the levels of soluble cytotoxic T associated antigen-4 (CTLA-4) and the CT-60 genotypes. J Autoimmun Dis 2:2–8.
- Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277.
- Takeuchi F, Kawasugi K, Nabeta H, Mori M, Tanimoto K. 2003. CTLA-4 dimorphisms in Japanese patients with systemic lupus erythematosus. Clin Exp Rheumatol 21:527–528.
- Torres B, Aguilar F, Franco E, Sanchez E, Sanchez-Roman J, Jimenez Alonso J, Nunez-Roldan A, Martin J, Gonzalez-Escribano MF. 2004. Association of the CT60 marker of the CTLA4 gene with systemic lupus erythematosus. Arthritis Rheum 50:2211–2215.
- Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Genova G 2003. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423:506–511.